UPMC Hillman Cancer Center

Research Funding Opportunities

Research Funding Opportunities

Show newest first

View funding announcements by clicking on the title. Click on the headings "Title", "Category" or "Deadline" to sort listings. Click here for FAQ about this webpage.

Title Category Deadline
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01) ALL 10/05/17
Methodology and Measurement in the Behavioral and Social Sciences (R01) ALL 10/05/17
Examination of Survivorship Care Planning Efficacy and Impact (R01) ALL 10/05/17
Gene Fusions in Pediatric Sarcomas (R01) CHLD 10/05/17
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01) ALL 10/05/17
The Role of Mobile Genetic Elements in Cancer (R21) ALL 10/16/17
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21) ALL 10/16/17
Methodology and Measurement in the Behavioral and Social Sciences (R21) ALL 10/16/17
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21) ALL 10/16/17
Metabolic Reprogramming to Improve Immunotherapy (R21) ALL 10/16/17
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21) ALL 10/16/17
Examination of Survivorship Care Planning Efficacy and Impact (R21) ALL 10/16/17
Gene Fusions in Pediatric Sarcomas (R21) CHLD 10/16/17
Neural Regulation of Cancer (R01) ALL 10/26/17
NCI Small Grants Program for Cancer Research (NCI Omnibus R03) ALL 10/26/17
Neural Regulation of Cancer (R21) ALL 10/26/17
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01) ALL 11/20/17
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) ALL 11/20/17
Advanced Development of Informatics Technologies for Cancer Research and Management (U24) ALL 11/20/17
Imaging and Biomarkers for Early Detection of Aggressive Cancer (U01) ALL 12/11/17
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2018, 2019, and 2020 (P50 Clinical Trial Required) ALL 01/25/18
Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25) ALL 01/25/18
Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25) ALL 01/25/18
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) ALL 01/25/18
Serious Adverse Drug Reaction Research (R21) ALL 02/01/18

Next 25 rows